about
Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016Zika Virus and Birth Defects — Reviewing the Evidence for CausalityUpdate: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak — Puerto Rico, 2016Preventing Transmission of Zika Virus in Labor and Delivery Settings Through Implementation of Standard Precautions — United States, 2016Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection — United States, February 2016Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection — United States, 2016Zika Virus and PregnancyWhat Obstetric Health Care Providers Need to Know About Measles and PregnancyEmerging and Zoonotic Infections in WomenCharacterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric CliniciansBlood flow and the degree of shunting through the ductus venosus in the human fetusVital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016Studying the effects of emerging infections on the fetus: Experience with West Nile and Zika virusesMaternal mortality due to pandemic influenza A H1N1 2009 virus in Colombia.2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature.Vitamin B12 deficiency in children and adolescents.Emerging infections and pregnancy.Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.Assessment of risk factors for infantile cataracts using a case-control study: National Birth Defects Prevention Study, 2000-2004Lymphocytic choriomeningitis virus: an emerging obstetric pathogen?Maternal thyroid disease as a risk factor for craniosynostosis.Infectious etiologies of chronic diseases: focus on women.Benefits of influenza vaccination during pregnancy for pregnant women.Priorities for future public health research in orofacial clefts.Effects of influenza on pregnant women and infants.Vaccines and pregnancy: past, present, and future.Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998.Ebola virus disease and children: what pediatric health care professionals need to know.Low risk of solid tumors in persons with Down syndrome.Methods for a public health response to birth defects clusters.2009 H1N1 influenza and pregnancy--5 years later.Pandemic influenza and pregnant women.Effective coding in birth defects surveillance.Maternal lifestyle factors and risk for ventricular septal defects.Maternal nutrient intakes and risk of orofacial clefts.Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999.Descriptive epidemiology of holoprosencephaly and arhinencephaly in metropolitan Atlanta, 1968-1992.Descriptive epidemiology of infantile cataracts in metropolitan Atlanta, GA, 1968-1998.
P50
Q23024073-552f54f7-473d-b46c-95f0-735677a0eca4Q23815222-e6a3714a-4453-5c4b-fd57-7cf8c3b20523Q24261157-d4a05247-40cd-b2ed-8d8e-74adb7b7ba7dQ24261158-aae02e41-4e21-ff53-acdf-debfd8e6f06dQ24261159-09ba6b8c-480b-a2b9-663b-77fb4a0c0b71Q24261161-30d1c1c3-4c7b-d036-5c42-08cb5b54dc51Q24261164-0f9a60cf-4c9b-4777-25fd-c906ba380d9cQ24261166-629b2fe8-4503-0194-3e8a-03f69a77df9bQ24261270-ddb23949-4d74-d20e-2d80-568bfedae948Q26865454-0A8842E9-FF34-4D27-8EA6-ABEBE4C846E2Q27487976-4E4044E1-D48F-4E63-8CBF-A8CD97EA8DCCQ27682414-c85dd641-499c-ee58-8a57-80eaf44c353eQ28143401-8BB44544-DAB4-4D3F-B82F-77162E479BB1Q29168666-2BA5B718-450E-4C54-BD6F-B25058199166Q29365300-A05A88CE-1B5F-488C-A6BF-03004DEC9F9BQ30354746-19133409-73E7-4466-8BC6-7826E58CF01DQ30400080-1C284D25-8C5F-4B5A-AE66-6A14008C20D5Q31811238-120FA81A-3A41-4544-8FEA-025E5A2DB622Q34002296-9D4151D1-3C75-4943-8E33-9843C9A80910Q34020644-8EF21DE1-C647-435C-8E58-F3CDA3DC748CQ34363799-9EE7DB1E-E76F-4F7C-B383-7B473AF9494EQ34531438-618ECB73-4AB0-429C-B6B1-7564523D6F24Q34658056-2BE4E86B-0B76-4697-96E9-D1D296E68278Q35896042-C956AA72-E6A6-4796-8624-1A7DA1F721A5Q36003849-24899AD1-F046-46E5-B4B7-92FC096A44B0Q36869277-9A6E449D-6E43-48EC-A40E-5737D6B9A474Q38037607-83A8DF40-F2ED-44ED-968B-B9886E4F61E6Q38172731-84533D2D-0FB6-471A-AD31-E9D8CA40E023Q39758534-5917ED80-CFA9-4CA1-A9EC-3D4D296B36DFQ40186436-19B46A4E-BE69-49FE-A70C-63805FA1E50CQ40506069-6B039EAA-B8C1-4926-A92B-393BE49E6A52Q40632894-90CE577C-C1CE-408C-A587-A59362E67AA1Q41711269-9D7B8ED6-9475-48FE-9577-649179B7CCB6Q43103192-E0C7F6CC-BA7D-4DD7-9483-97B266992DAAQ44674215-77628B70-FF96-4D5C-A980-8DD21244BFBCQ44781303-479169F9-B6D3-4BAB-8FE8-EC74C3F36282Q45992602-A1A234D5-0F58-43B6-9CEF-E06CEF90979AQ46348765-7BCE83F0-FA1B-4819-A71D-C3B2E16E45CAQ46360105-0C7024D8-8693-4839-90C0-7D5DF3E3CEC4Q47974122-209864CB-FECA-4CFD-B596-9981B9F00164
P50
description
amerikansk forsker
@da
pediatrician and medical geneticist
@en
wetenschapper
@nl
name
Sonja A. Rasmussen
@ast
Sonja A. Rasmussen
@da
Sonja A. Rasmussen
@de
Sonja A. Rasmussen
@en
Sonja A. Rasmussen
@es
Sonja A. Rasmussen
@fo
Sonja A. Rasmussen
@fr
Sonja A. Rasmussen
@is
Sonja A. Rasmussen
@kl
Sonja A. Rasmussen
@nb
type
label
Sonja A. Rasmussen
@ast
Sonja A. Rasmussen
@da
Sonja A. Rasmussen
@de
Sonja A. Rasmussen
@en
Sonja A. Rasmussen
@es
Sonja A. Rasmussen
@fo
Sonja A. Rasmussen
@fr
Sonja A. Rasmussen
@is
Sonja A. Rasmussen
@kl
Sonja A. Rasmussen
@nb
altLabel
Sonja Rasmussen
@en
prefLabel
Sonja A. Rasmussen
@ast
Sonja A. Rasmussen
@da
Sonja A. Rasmussen
@de
Sonja A. Rasmussen
@en
Sonja A. Rasmussen
@es
Sonja A. Rasmussen
@fo
Sonja A. Rasmussen
@fr
Sonja A. Rasmussen
@is
Sonja A. Rasmussen
@kl
Sonja A. Rasmussen
@nb
P106
P1960
7qmetaoAAAAJ
P21
P31
P496
0000-0002-0574-4928
P569
2000-01-01T00:00:00Z